Malaria pill may calm lupus skin flares, new trial hopes
NCT ID NCT07557927
First seen May 02, 2026 · Last updated May 02, 2026
Summary
This study tests if dihydroartemisinin, a malaria drug, can safely reduce skin lesions in people with discoid lupus erythematosus (DLE). About 100 adults aged 18-65 will receive either the study drug or an active comparator for 24 weeks. The main goal is to measure changes in the severity and area of skin involvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISCOID LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
-
Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
-
Peking University People's Hospital
Beijing, Beijing Municipality, China
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
-
The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
-
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.